Core Viewpoint - Aerospace Power's stock price has shown significant growth this year, with a year-to-date increase of 61.43% and a recent uptick in trading activity, indicating strong investor interest and market performance [2][3]. Group 1: Stock Performance - As of November 17, Aerospace Power's stock price rose by 2.11% to 16.95 CNY per share, with a trading volume of 1.15 billion CNY and a market capitalization of 10.818 billion CNY [1]. - The stock has increased by 7.76% over the last five trading days, 19.20% over the last 20 days, and 12.33% over the last 60 days [2]. Group 2: Financial Performance - For the period from January to September 2025, Aerospace Power reported a revenue of 510 million CNY, a year-on-year decrease of 14.19%, and a net profit attributable to shareholders of -109 million CNY, down 31.21% year-on-year [3]. - The company has not distributed any dividends in the last three years, with a total payout of 198 million CNY since its A-share listing [4]. Group 3: Shareholder and Market Activity - As of September 30, 2025, the number of shareholders increased to 73,100, with an average of 8,730 circulating shares per shareholder, a decrease of 2.38% [3]. - The top ten circulating shareholders include new entrants such as Changcheng Jiujia Innovation Growth Mixed Fund, holding 5.45 million shares, while Hong Kong Central Clearing Limited reduced its holdings by 1.78 million shares [4].

Core Viewpoint - Baiotai's stock price has shown a year-to-date increase of 34.93%, but recent trading indicates a decline in the short term, with a notable drop of 21.45% over the past 60 days [2] Company Overview - Baiotai Biopharmaceutical Co., Ltd. is located in Guangzhou, Guangdong Province, and was established on July 28, 2003, with its listing date on February 21, 2020 [2] - The company focuses on the research and production of innovative drugs and biosimilars, with its main business revenue composition being: 91.90% from drug sales, 6.55% from licensing, 0.90% from contract manufacturing, and 0.65% from technical services [2] Financial Performance - For the period from January to September 2025, Baiotai achieved an operating income of 684 million yuan, representing a year-on-year growth of 17.57%, while the net profit attributable to shareholders was -224 million yuan, reflecting a year-on-year increase of 38.72% [2] Stock Market Activity - As of November 17, Baiotai's stock price was 26.15 yuan per share, with a trading volume of 13.01 million yuan and a turnover rate of 0.12%, resulting in a total market capitalization of 10.828 billion yuan [1] - The net outflow of main funds was 120,900 yuan, with large single purchases amounting to 588,900 yuan (4.53% of total) and sales of 709,800 yuan (5.45% of total) [1] Shareholder Information - As of September 30, 2025, the number of Baiotai's shareholders was 9,397, a decrease of 0.89% from the previous period, with an average of 44,065 circulating shares per person, an increase of 0.89% [2] - Hong Kong Central Clearing Limited is the tenth largest circulating shareholder, holding 6.0247 million shares as a new shareholder [2]

Core Viewpoint - The stock of Youyan Silicon has experienced fluctuations, with a recent decline of 2.17% on November 17, 2023, and a year-to-date increase of 20.28% [1] Financial Performance - For the period from January to September 2025, Youyan Silicon reported revenue of 747 million yuan, a year-on-year decrease of 3.43%, and a net profit attributable to shareholders of 156 million yuan, down 19.81% year-on-year [2] - Cumulative cash dividends since the A-share listing amount to 162 million yuan [3] Shareholder Information - As of September 30, 2025, the number of shareholders for Youyan Silicon increased by 7.44% to 22,000, while the average circulating shares per person decreased by 6.93% to 23,057 shares [2] - The top ten circulating shareholders include notable entities such as the Harvest SSE STAR Chip ETF and Hong Kong Central Clearing Limited, with some new entrants and reductions in holdings among existing shareholders [3] Stock Performance - As of November 17, 2023, Youyan Silicon's stock price was 13.52 yuan per share, with a market capitalization of 16.868 billion yuan [1] - The stock has shown a 1.02% decline over the last five trading days, a 9.39% increase over the last 20 days, and an 11.09% increase over the last 60 days [1] Business Overview - Youyan Silicon, established on June 21, 2001, and listed on November 10, 2022, specializes in the research, production, and sales of semiconductor materials [1] - The company's main revenue sources include semiconductor silicon wafers (61.48%), silicon materials for etching equipment (29.55%), and other segments [1] Industry Classification - Youyan Silicon is classified under the electronic-semiconductor-semiconductor materials sector and is part of various concept sectors including mid-cap, margin trading, and specialized innovation [1]

Core Viewpoint - Hezhong Electric's stock price has shown significant volatility, with a year-to-date increase of 59.73%, but recent trading indicates a mixed performance in the short term [1][2]. Group 1: Stock Performance - On November 17, Hezhong Electric's stock fell by 2.01%, trading at 31.69 yuan per share, with a total market capitalization of 14.506 billion yuan [1]. - The stock has experienced a 3.90% increase over the last five trading days, a 0.69% decrease over the last 20 days, and a 16.21% decrease over the last 60 days [1]. - Year-to-date, Hezhong Electric has appeared on the trading leaderboard seven times, with the most recent instance on August 12, where it recorded a net buy of -274 million yuan [1]. Group 2: Financial Performance - For the period from January to September 2025, Hezhong Electric reported a revenue of 2.778 billion yuan, reflecting a year-on-year growth of 20.19%, and a net profit attributable to shareholders of 334 million yuan, up 31.99% year-on-year [2]. - Since its A-share listing, Hezhong Electric has distributed a total of 299 million yuan in dividends, with 170 million yuan distributed over the past three years [3]. Group 3: Shareholder Information - As of October 31, 2025, Hezhong Electric had 72,000 shareholders, an increase of 2.09% from the previous period, with an average of 6,358 circulating shares per shareholder, a decrease of 2.05% [2]. - The second-largest circulating shareholder is Hong Kong Central Clearing Limited, holding 10.5675 million shares, a decrease of 2.9177 million shares from the previous period [3]. - New entrants among the top ten circulating shareholders include Agricultural Bank of China New Energy Mixed A, holding 3.9564 million shares, and Huaxia CSI 1000 ETF, holding 2.4647 million shares [3].

Core Viewpoint - Andeli's stock price has experienced fluctuations, with a year-to-date increase of 44.47% but a recent decline of 12.48% over the last five trading days [1] Group 1: Stock Performance - As of November 17, Andeli's stock price was 39.47 CNY per share, with a market capitalization of 13.467 billion CNY [1] - The stock has seen a trading volume of 13.81 million CNY, with a turnover rate of 0.13% [1] - Year-to-date, Andeli's stock has been on the leaderboard five times, with the latest instance on November 11, showing a net buy of -30.0717 million CNY [1] Group 2: Financial Performance - For the period from January to September 2025, Andeli reported a revenue of 1.321 billion CNY, representing a year-on-year growth of 28.88% [2] - The net profit attributable to shareholders for the same period was 284 million CNY, reflecting a year-on-year increase of 43.38% [2] Group 3: Shareholder Information - As of September 30, 2025, the number of Andeli's shareholders was 7,021, a decrease of 23.74% from the previous period [2] - The average number of circulating shares per person increased by 31.22% to 38,631 shares [2] - Since its A-share listing, Andeli has distributed a total of 234 million CNY in dividends, with 198 million CNY distributed over the last three years [3]

Core Viewpoint - Yonghe Co., Ltd. has experienced a stock price decline of 2.02% on November 14, with a current price of 27.63 CNY per share and a total market capitalization of 14.112 billion CNY. The company has seen a year-to-date stock price increase of 37.60% [1] Financial Performance - For the period from January to September 2025, Yonghe Co., Ltd. achieved a revenue of 3.786 billion CNY, representing a year-on-year growth of 12.04%. The net profit attributable to shareholders reached 469 million CNY, showing a significant increase of 220.39% compared to the previous year [2] Shareholder Information - As of September 30, 2025, the number of shareholders for Yonghe Co., Ltd. increased to 24,000, a rise of 29.73% from the previous period. The average number of circulating shares per shareholder is 20,908, which is an increase of 2.23% [2] Dividend Distribution - Since its A-share listing, Yonghe Co., Ltd. has distributed a total of 310 million CNY in dividends, with 242 million CNY distributed over the past three years [3] Institutional Holdings - As of September 30, 2025, among the top ten circulating shareholders, Xin'ao Cycle Power Mixed A (010963) is the seventh largest, holding 6.2843 million shares, an increase of 3.1695 million shares from the previous period. Hong Kong Central Clearing Limited is the eighth largest shareholder, holding 6.2477 million shares as a new shareholder [3]

11月14日，奥赛康盘中上涨2.01%，截至10:46，报19.78元/股，成交2.00亿元，换手率1.10%，总市值 183.59亿元。 资金流向方面，主力资金净流入424.22万元，特大单买入114.65万元，占比0.57%，卖出0.00元，占比 0.00%；大单买入3167.53万元，占比15.86%，卖出2857.96万元，占比14.31%。 奥赛康今年以来股价涨57.11%，近5个交易日涨6.75%，近20日涨1.59%，近60日跌25.44%。 今年以来奥赛康已经2次登上龙虎榜，最近一次登上龙虎榜为7月16日。 资料显示，北京奥赛康药业股份有限公司位于江苏省南京市江宁科学园科建路699号，成立日期1996年 12月24日，上市日期2015年5月15日，公司主营业务涉及消化类、抗肿瘤类及其他药品的研发、生产和 销售。主营业务收入构成为：抗肿瘤类38.28%，抗感染类24.74%，慢性病类21.65%，消化类12.33%， 其他(补充)2.34%，其他类0.66%。 奥赛康所属申万行业为：医药生物-化学制药-化学制剂。所属概念板块包括：抗癌治癌、创新药、生物 医药、幽门螺杆概念、中盘等。 截至10月2 ...

11月14日，博瑞医药（维权）盘中上涨2.02%，截至10:39，报55.49元/股，成交3.19亿元，换手率 1.37%，总市值234.78亿元。 资金流向方面，主力资金净流入1714.71万元，特大单买入1799.70万元，占比5.65%，卖出1781.45万 元，占比5.59%；大单买入9794.36万元，占比30.73%，卖出8097.89万元，占比25.41%。 博瑞医药今年以来股价涨84.33%，近5个交易日涨4.27%，近20日涨8.17%，近60日跌51.15%。 责任编辑：小浪快报 资料显示，博瑞生物医药(苏州)股份有限公司位于江苏省苏州工业园区星湖街218号纳米科技园C25-C28 栋,香港铜锣湾勿地臣街1号时代广场2座31楼，成立日期2001年10月26日，上市日期2019年11月8日，公 司主营业务涉及研发和生产高端仿制药和原创性新药。主营业务收入构成为：产品销售收入89.90%， 技术权益及服务收入6.77%，其他(补充)3.33%。 博瑞医药所属申万行业为：医药生物-化学制药-原料药。所属概念板块包括：仿制药、生物医药、创新 药、多肽药、中盘等。 机构持仓方面，截止2025年9月3 ...

Core Viewpoint - Lichong Group's stock has experienced fluctuations, with a year-to-date increase of 57.86% and a recent decline of 1.29% over the last five trading days, indicating volatility in market performance [1]. Financial Performance - For the period from January to September 2025, Lichong Group achieved a revenue of 22.921 billion yuan, representing a year-on-year growth of 18.34%. The net profit attributable to shareholders was 625 million yuan, reflecting a year-on-year increase of 26.77% [2]. - Cumulatively, Lichong Group has distributed 730 million yuan in dividends since its A-share listing, with 339 million yuan distributed over the past three years [3]. Shareholder Information - As of October 10, 2025, the number of shareholders for Lichong Group increased to 33,400, up by 12.31% from the previous period. The average number of circulating shares per shareholder decreased by 10.96% to 16,688 shares [2]. - The fifth largest circulating shareholder, Hong Kong Central Clearing Limited, increased its holdings by 10.8443 million shares, totaling 14.4197 million shares [3]. Business Overview - Lichong Group, established on July 28, 1998, and listed on March 19, 2015, is primarily engaged in the research, production, and sales of aluminum alloy wheels, lightweight and functional intermediate alloy new materials, and cast aluminum alloys. The revenue composition includes 54.50% from cast aluminum alloys, 33.23% from aluminum alloy wheels, 7.81% from intermediate alloys, and 4.46% from other sources [1]. - The company operates within the automotive industry, specifically in the automotive parts sector, and is associated with concepts such as lithium batteries, new materials, margin financing, mid-cap stocks, and sodium batteries [1].

Core Insights - The stock price of Dajin Heavy Industry increased by 2.19% on November 14, reaching 47.05 CNY per share, with a total market capitalization of 30.006 billion CNY [1] - The company has seen a significant stock price increase of 131.50% year-to-date, with a recent decline of 0.84% over the last five trading days [1] - Dajin Heavy Industry's main business includes the production and sales of wind power tower frames and thermal power boiler steel structures, with wind power equipment accounting for 94.54% of its revenue [1] Financial Performance - For the period from January to September 2025, Dajin Heavy Industry reported a revenue of 4.595 billion CNY, representing a year-on-year growth of 99.25%, and a net profit attributable to shareholders of 888 million CNY, up 214.63% year-on-year [2] - The company has distributed a total of 325 million CNY in dividends since its A-share listing, with 240 million CNY distributed over the past three years [3] Shareholder Structure - As of October 31, 2025, the number of shareholders for Dajin Heavy Industry increased to 67,300, a rise of 15.29%, while the average number of tradable shares per shareholder decreased by 13.26% to 9,381 shares [2] - The second-largest shareholder is Hong Kong Central Clearing Limited, holding 22.0823 million shares, an increase of 2.6702 million shares from the previous period [3] - New institutional shareholders include Southern CSI 1000 ETF and Dongfanghong Qiyuan Three-Year Holding Mixed A, which have entered the top ten circulating shareholders list [3]